Routine

Glucocorticoid-induced myopathy

Steroid-related proximal weakness · Rheumatology
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

A common complication of prolonged or high-dose corticosteroid therapy producing painless proximal muscle weakness, typically of the hip girdle, with a normal creatine kinase. The key challenge is distinguishing it from a flare of the underlying inflammatory myopathy, which would warrant more steroid rather than less.

Red flags

  • Rising CK (suggests myositis flare, not steroid myopathy)
  • Rapidly progressive weakness
  • Respiratory or bulbar muscle involvement
  • Marked muscle pain or tenderness
  • Falls and loss of mobility

Assessment

Differential diagnosis

  • Active inflammatory myopathy flare
  • Disuse atrophy / deconditioning
  • Hypothyroid or other endocrine myopathy
  • Electrolyte disturbance (hypokalaemia, hypophosphataemia)
  • Statin / drug-induced myopathy
  • Critical illness myopathy

Investigations

  • Creatine kinase (characteristically normal in steroid myopathy)
  • Electrolytes including potassium, phosphate, magnesium
  • Thyroid function
  • EMG (myopathic without irritability; may be normal)
  • Review of steroid dose, duration and timeline against symptom onset
  • Muscle MRI/biopsy only if diagnosis remains unclear

Management

  • Correlate the timeline of weakness with steroid dose and duration
  • Use a normal CK and absence of inflammatory features to differentiate from a myositis flare
  • Exclude electrolyte, thyroid and other drug causes of weakness
  • Reduce the glucocorticoid dose to the lowest effective level and consider steroid-sparing agents
  • Switch from fluorinated steroids (dexamethasone, triamcinolone) to non-fluorinated where possible
  • Encourage graded resistance and aerobic exercise / physiotherapy
  • Ensure adequate protein intake and treat vitamin D deficiency
  • Monitor strength to confirm improvement as steroids are reduced (confirms the diagnosis)

Drugs & doses

Reduce prednisolone to lowest effective dose; aim to taper where disease allows
Switch fluorinated steroid to prednisolone (non-fluorinated) if feasible
Colecalciferol — 800-2000 units PO OD if vitamin D deficient
Steroid-sparing agent (e.g. methotrexate 15-25 mg weekly) to allow steroid reduction

Disposition

Outpatient management with steroid minimisation and physiotherapy; admission rarely required.

Complications & pitfalls

  • Falls and fractures
  • Loss of mobility and independence
  • Difficulty distinguishing from myositis flare leading to inappropriate dose changes
  • Deconditioning

Exam pearls

  • Normal CK with proximal weakness in a steroid-treated patient points to steroid myopathy, not a flare
  • Fluorinated steroids (dexamethasone, triamcinolone) are more myotoxic
  • Improvement with dose reduction and exercise confirms the diagnosis retrospectively
  • Rising CK should make you suspect active myositis instead

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.